Sort
48,018 grants matching “immunotherapy”
Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in Thailand
$427,769Kathryn B Anderson · Upstate Medical University · R01 · FY2025 · AI
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
$427,763Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
$427,763Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2022 · CA
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
$427,763Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · CA
Project-001
$427,763Margaret M Madeleine · Fred Hutchinson Cancer Research Center · U54 · FY2020 · CA
Cocaine Vaccine for Methadone Maintained Patients
$427,742Yale University · R01 · FY2004 · DA
ALDH Inhibition as Modulator of Tumor Immunobiology
$427,724Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2023 · CA
Immunization to Block the Effects of Nicotine
$427,720Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2012 · DA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$427,661Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · CA
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$427,654Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2020 · CA
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
$427,625Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R21 · FY2023 · NS
A Novel Vector Platform to Actualize T Cell Modification In Vivo
$427,625David T Curiel · Washington University · R21 · FY2023 · EB
Joint receptor and protein expression immunophenotyping through split-pool barcoding
$427,567Georg Seelig · University Of Washington · R33 · FY2021 · CA
EXPRESSION OF TUBERCULOSIS IN THE LUNG
$427,540Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2000 · HL
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
$427,516Andrew J Armstrong · Duke University · R01 · FY2019 · CA
Exploiting Public Metagenomic Data to Uncover Cancer-Microbiome Relationships
$427,476Levi Waldron · Graduate School Of Public Health And Health Policy · R01 · FY2024 · CA
Exploiting Public Metagenomic Data to Uncover Cancer-Microbiome Relationships
$427,475Levi Waldron · Graduate School Of Public Health And Health Policy · R01 · FY2025 · CA
Chimeric Anti CD20 T Cell Receptors for Lymphoma Therapy
$427,470Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA
HIV-1 gp120 induced CTL chemorepulsion:dysregulation of migration & localization
$427,464Mark Coleman Poznansky · Massachusetts General Hospital · R01 · FY2010 · AI
EPITHELIAL OVARIAN CANCER PROGRAM PROJECT
$427,461Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines
$427,406Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$427,384Xiang Zhang · Baylor College Of Medicine · R01 · FY2019 · CA
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
$427,345Rulla M Tamimi · Weill Medical Coll Of Cornell Univ · U01 · FY2025 · CA
Regulation of CD8+T cells by Zbtb42
$427,257Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2023 · CA
Exploiting immunostimulatory microbial pattern recognition to improve head and neck cancer therapy
$427,208Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2025 · DE